[
  {
    "ts": "2025-09-08T14:14:29+00:00",
    "headline": "Quest Diagnostics (DGX): Assessing Valuation Following Launch of Nationwide Pharmacogenomic Test for Precision Medicine",
    "summary": "Quest Diagnostics (DGX) recently caught the market’s eye with the launch of an advanced pharmacogenomic laboratory test. The new test aims to help healthcare providers personalize drug therapies based on a patient’s genetic profile. Supported by Coriell Life Sciences technology, this service is positioned as a game changer for clinicians across a wide range of specialties. It offers actionable guidance that could make prescribing both safer and more effective. This launch also signals a...",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-assessing-valuation-141429190.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "3ba2a0b9-d63d-382d-b8e9-fffd2eae96c6",
      "content": {
        "id": "3ba2a0b9-d63d-382d-b8e9-fffd2eae96c6",
        "contentType": "STORY",
        "title": "Quest Diagnostics (DGX): Assessing Valuation Following Launch of Nationwide Pharmacogenomic Test for Precision Medicine",
        "description": "",
        "summary": "Quest Diagnostics (DGX) recently caught the market’s eye with the launch of an advanced pharmacogenomic laboratory test. The new test aims to help healthcare providers personalize drug therapies based on a patient’s genetic profile. Supported by Coriell Life Sciences technology, this service is positioned as a game changer for clinicians across a wide range of specialties. It offers actionable guidance that could make prescribing both safer and more effective. This launch also signals a...",
        "pubDate": "2025-09-08T14:14:29Z",
        "displayTime": "2025-09-08T14:14:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pUPV1p_Bw8ydOCyP5dgMaw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SLvgYYeIn3Dw6STv9CZZCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-assessing-valuation-141429190.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-assessing-valuation-141429190.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-08T04:04:25+00:00",
    "headline": "3 Reasons to Sell DGX and 1 Stock to Buy Instead",
    "summary": "Even though Quest (currently trading at $183.49 per share) has gained 6% over the last six months, it has lagged the S&P 500’s 15.5% return during that period. This might have investors contemplating their next move.",
    "url": "https://finance.yahoo.com/news/3-reasons-sell-dgx-1-040425158.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "980cff75-d91a-3128-b6ec-4f0e70f24add",
      "content": {
        "id": "980cff75-d91a-3128-b6ec-4f0e70f24add",
        "contentType": "STORY",
        "title": "3 Reasons to Sell DGX and 1 Stock to Buy Instead",
        "description": "",
        "summary": "Even though Quest (currently trading at $183.49 per share) has gained 6% over the last six months, it has lagged the S&P 500’s 15.5% return during that period. This might have investors contemplating their next move.",
        "pubDate": "2025-09-08T04:04:25Z",
        "displayTime": "2025-09-08T04:04:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/a002c113304d0049242cefeebcf6d343",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "DGX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aeh65E_EG08O8chSqy1MVw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/a002c113304d0049242cefeebcf6d343.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l7C10YsggYCA0fc.htm8Ww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/a002c113304d0049242cefeebcf6d343.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-sell-dgx-1-040425158.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-sell-dgx-1-040425158.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]